Company Filing History:
Years Active: 2016
Title: Olga Lidia Pérez Guevara: Innovator in Vaccine Development
Introduction
Olga Lidia Pérez Guevara is a prominent inventor based in La Habana, Cuba. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines. Her work focuses on combating viral diseases, showcasing her dedication to public health and scientific advancement.
Latest Patents
Olga holds a patent for a dengue virus vaccine composition. This innovative vaccine comprises at least one antigen based on the dengue virus capsid protein and an oligonucleotide identified as SEQ ID NO 1. The composition includes a fusion protein formed by the DV2 capsid and domain III of the envelope protein, which has been shown to elicit higher levels of cellular immune response and protection in mice compared to previous formulations. The efficacy of this vaccine composition has been demonstrated in non-human primates, indicating its potential for real-world application. The compositions can be monovalent, bivalent, or tetravalent, designed to induce a functional immune response to the four viral serotypes.
Career Highlights
Olga is affiliated with the Centro de Ingeniería Genética y Biotecnología, where she conducts her research and development work. Her career is marked by a commitment to advancing vaccine technology and improving health outcomes through innovative solutions.
Collaborations
One of her notable collaborators is Lázaro Gil González, with whom she has worked closely on various projects related to vaccine development.
Conclusion
Olga Lidia Pérez Guevara is a trailblazer in the field of vaccine innovation, with her work on dengue virus vaccine compositions paving the way for future advancements in public health. Her contributions are vital in the ongoing fight against viral diseases, and her dedication to research continues to inspire others in the scientific community.